1. Home
  2. ARVN vs MEC Comparison

ARVN vs MEC Comparison

Compare ARVN & MEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

N/A

Current Price

$7.85

Market Cap

600.2M

Sector

Health Care

ML Signal

N/A

Logo Mayville Engineering Company Inc.

MEC

Mayville Engineering Company Inc.

N/A

Current Price

$17.58

Market Cap

527.1M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ARVN
MEC
Founded
2015
1945
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
600.2M
527.1M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
ARVN
MEC
Price
$7.85
$17.58
Analyst Decision
Buy
Strong Buy
Analyst Count
19
3
Target Price
$15.05
$24.33
AVG Volume (30 Days)
705.4K
419.8K
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
58.84
N/A
EPS
1.70
N/A
Revenue
$262,600,000.00
N/A
Revenue This Year
N/A
$10.65
Revenue Next Year
N/A
$8.66
P/E Ratio
$4.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.97
$12.25
52 Week High
$14.22
$38.76

Technical Indicators

Market Signals
Indicator
ARVN
MEC
Relative Strength Index (RSI) 33.46 27.34
Support Level N/A $17.20
Resistance Level $9.69 $19.72
Average True Range (ATR) 0.32 0.99
MACD -0.11 0.17
Stochastic Oscillator 0.58 13.44

Price Performance

Historical Comparison
ARVN
MEC

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, powersports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly, and logistic services.

Share on Social Networks: